Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us  
Google
Web www.equitybulls.com
Research

| More

REDUCE on ICICI Lombard - COR continues to improve - HDFC Securities

Posted On: 2020-10-26 04:37:05


Mr. Madhukar Ladha, Institutional Research Analyst, HDFC Securities

While FY21E is expected to be a muted year in terms of top-line growth, we believe ICICIGI will deliver lower CORs. We remain cautious on health claims as a second wave of COVID-19 may result in significant increase in claims. Additionally, changing regulations in motor are expected to drive down both claims and tariffs, creating supernormal profitability in the short term. We believe that this period (of supernormal profitability) will be short-lived, as we expect IRDAI to restrict TP pricing growth, thereby restricting profitability. We believe the market is not factoring this risk; accordingly, we rate ICICIGI a REDUCE with a target price of Rs 1,141 (DDM derived Sep-22E P/E of 26.4x and a P/ABV of 5.2x).

2QFY21 highlights: (1) NEP was in-line (+0.5% vs. estimates) at Rs 24.6bn (4.5/6.0% YoY/QoQ) as 2Q saw partial easing of lock-down. Motor/Health GDPI grew 9.4/8.3% YoY. The company has grown motor OD business selectively in categories which it believes it can make profits. Within health, retail indemnity business grew 30.9% YoY in 1HFY21, while group business growth was muted at -7.2% YoY due to lower credit off-take. Loss ratios for motor OD were contained at 58.9 (-1,290/-400bps YoY/QoQ) and motor TP at 61.6% (-2,480/-860bps YoY/QoQ), as management had been conservatively providing in previous periods. Loss ratios for health shot up to 81.9% (1,090/640bps YoY/QoQ) as both COVID claims and elective surgeries witnessed a significant surge. Overall, 2QFY21 CoR (calculated) was at 100.7% (-307/+143bps YoY/QoQ) vs. management reported CoR of 99.7% (-290/+0bps YoY/QoQ). Investment yield (including unrealised MTM) was 12.1% (+573/-122bps YoY/QoQ). Reversal of investment provisioning resulted in the company posting an APAT of Rs 4.39bn +27.0/3.9% YoY/QoQ, +7.4% vs. estimate).

Outlook: We expect FY21E to be a muted year in terms of NEP growth (FY21E: 8.3% YoY); however, given the partial re-opening conditions and lower economic activity loss ratios in most lines (except health) are expected to improve. Overall, CoRs are expected to improve in FY21E to 96.8% (-520bps YoY). Health loss ratios may get impacted adversely if the COVID-19 pandemic is not arrested.

Shares of ICICI Lombard General Insurance Company Ltd was last trading in BSE at Rs.1255 as compared to the previous close of Rs. 1257.5. The total number of shares traded during the day was 9264 in over 1307 trades.

The stock hit an intraday high of Rs. 1293.1 and intraday low of 1237.5. The net turnover during the day was Rs. 11676399.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com



Disclaimer:The article above is a gist / extract of the original report prepared by the research firm / brokerage firm. This article is not to be considered as an offer to sell or a solicitation to buy any securities. This article is meant for general information only. www.equitybulls.com, its employees or owners or the research firms, its employees or owners won't be responsible for any liability that may arise from information, errors or omissions in these articles. www.equitybulls.com or its employees or owners / the research firms or its employees or clients or owners may from time to time hold positions in securities referred in this article. For detailed research reports, please contact the concerned research firm directly.





Other Headlines:

Initiating Coverage on Godrej Properties - The housing factory - HDFC Securities

Burger King IPO - Angel Broking

Rollover Analysis - Record foreign inflows pushes Nifty to 13k - YES Securities

Ceramic tiles industry - Market share gains sustain for top branded players - ICICI Securities

Gas sector - CGD: Competition to hit margins, volumes and lead to derating - ICICI Securities

Cement - Prices resilient in Q3; consensus upgrades to continue - ICICI Securities

Specialty chemicals - Price trend in Sep-20 - ICICI Securities

Timken India - Q2FY21 Company Update - ICICI Direct

Upgrade in target price of IDFC First Bank - Angel Broking

Laurus Labs stake acquisition in Richore Lifesciences - Angel Broking

Shares of Lakshmi Vilas Bank (LVB) suspended from trading - Angel Broking

Initiating Coverage on Sundram Fasteners - Fastening growth - HDFC Securities

Astral Poly Technik - Scalability to further improve with storage tanks foray - ICICI Securities

Vardhman Special Steel - Q2FY21 Company Update - ICICI Direct

Initiating Coverage - Advanced Enzyme Technologies - ICICI Direct

L&T - Secures Large Contract - Nov 25, 2020 - Angel Broking

Alembic Pharmaceuticals - Tentative Approval for JV - Angel Broking

Drug launch by Lupin - Tacrolimus Capsules - Angel Broking

Gujarat Gas - Nov 25, 2020 - Angel Broking

Metropolis Healthcare - Nov 25, 2020 - Angel Broking

NTPC - Showcase of strength & competitiveness - ICICI Securities

Telecom - Market Share TRACKER - Bharti is narrowing the gap on incremental market share vs RJio - ICICI Securities

Cochin Shipyard - Q2FY21 Result Update - ICICI Direct

Engineers India - Q2FY21 Result Update - ICICI Direct

Rupee - Nov 24, 2020 - Reliance Securities

FMCG Sector Update - Recovery unlocked; lower growth divergence - HDFC Securities

Engineers India - Consultancy segment outperformance - ICICI Securities

Engineers India - Q2 FY21 Result Update - YES SECURITIES

Motherson Sumi Systems - Company Update - Virtual Investor Conference - ICICI Direct

Mutual Fund Review - November, 2020 - ICICI Direct

Sadbhav Engineering - Q2FY21 Company Update - ICICI Direct

IRB Infrastructure - Q2FY21 Company Update - ICICI Direct

Vodafone Idea fund raising - Angel Broking

Rupee - Nov 23, 2020 - Reliance Securities

Crude Oil - Nov 23, 2020 - Reliance Securities

Q2FY21 Bank Result Quick Review - Angel Broking

Banks & NBFC's Sector Update Report - Yet another watershed moment? - HDFC Securities

Galaxy Surfactants - EBITDA/kg has an upside risk - ICICI Securities

Diagnostics - COVID-19 tests continue to trend higher - ICICI Securities

Banking & Financial Services - Sector Update - Nov 22, 2020 - ICICI Direct

Dalmia Bharat Sugar - Q2FY21 Company Update - ICICI Direct

Balkrishna Industries - Industry export growth momentum continues - ICICI Securities

Covid Recovery Pulse - Festive positivity continues in auto retails, E-way bill generation improves... - ICICI Direct

Quant Pick - Exide Industries - ICICI Direct

Shankara Building Products - Q2FY21 Company Update - ICICI Direct

Triveni Engineering - Q2FY21 Company Update - ICICI Direct

Initiating Coverage on Sudarshan Chemical - Leaping into the league of giants - HDFC Securities

Earnings Wrap Q2FY21: Earnings outperform, post Covid recovery picks up steam - ICICI Direct

Vodafone Idea Positive development beneficial for IDFC first bank - Angel Broking

Lakshmi Vilas Bank - Angel Broking



Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019